10 things to know about cder’s pharmaceutical quality functions
Published Streamed 3 months ago • 370 plays • Length 50:51Download video MP4
Download video MP3
Similar videos
-
55:15
quality management maturity (qmm) program #cder #fda
-
19:16
pharmaceutical quality policies: what you need to know (10/15) global quality
-
11:36
keynote: pharmaceutical quality: a global priority (cder) (1/15) global quality
-
18:59
office of pharmaceutical quality (opq) update
-
26:22
application manufacturing assessment (4of33) quality – oct. 16-17, 2019
-
38:20
office of pharmaceutical quality (opq) reorganization webinar
-
17:43
bioavailability/bioequivalence site evaluation during the pandemic
-
20:14
generic drug product quality assessment (22of27) generic drugs forum 2018
-
1:18:40
cder’s role in public health emergency response and medical countermeasure development
-
32:20
503b compounder product reporting using cder direct – drls workshop 2020
-
6:07
keynote overview – cder compliance conference
-
16:35
application communications – quality assessment perspective
-
20:06
major issues and facilities in drug master files (9/15) global quality
-
16:13
keynote: cder’s commitment to pharmaceutical quality (1of33) quality – oct. 16-17, 2019
-
17:42
improving the sterility assurance application to the fda – generic drugs forum (gdf) 2024
-
52:06
bioassays 2020 keynote: steven kozlowski, cder, fda
-
26:11
continuous manufacturing of drug product (20of33) quality – oct. 16-17, 2019
-
1:16:43
fda | nih: regulatory do’s and don'ts: tips from fda – cder segment
-
22:17
pharmaceutical quality surveillance program (14of33) quality – oct. 16-17, 2019